Gyre Therapeutics, Inc. GYRE Gyre — Segment Expenditure Addition To Long Lived Assets

Other segment segments

Similar metrics at other companies

EXPCement — Segment Expenditure Addition To Long Lived Assets

$66.86M+45.4%

NUSHong Kong Taiwan — Segment Expenditure Addition To Long Lived Assets

$15K-71.2%

FSISegment Expenditure Addition To Long Lived Assets

$2.23M+531%

RDI

RDIAll Segments — Segment Expenditure Addition To Long Lived Assets

$556K+36.9%

MLMReportable Segments — Segment Expenditure Addition To Long Lived Assets

$2.51B+1,801%

CCAll Segments — Segment Expenditure Addition To Long Lived Assets

$43M+2.4%

FAQ

What is Gyre Therapeutics, Inc.'s gyre — segment expenditure addition to long lived assets?

Gyre Therapeutics, Inc. (GYRE) reported gyre — segment expenditure addition to long lived assets of $54K in Q2 2026.

How has Gyre Therapeutics, Inc.'s gyre — segment expenditure addition to long lived assets changed year-over-year?

Gyre Therapeutics, Inc.'s gyre — segment expenditure addition to long lived assets decreased by 31.6% year-over-year, from $79K to $54K.

What does gyre — segment expenditure addition to long lived assets mean?

This metric tracks the capital expenditures made by the segment to acquire or improve long-lived assets, such as property, plant, and equipment. It reflects the segment's investment in infrastructure and capacity to support long-term growth and operational capabilities. High levels of expenditure indicate active investment in the segment's future productive capacity.